Education
About Us
Working with TipRanks
Follow Us
Bjarke Henric Bjorn Insider Profile
11 Followers
Bjarke Henric Bjorn, SVP & CCO at IVERIC bio, holds 105.44K shares in Inozyme Pharma (Ticker: INZY), holds 1.30K shares in IVERIC bio (Ticker: ISEE). Most recently, Bjarke Henric Bjorn Bought ― shares of Inozyme Pharma on Dec 19, 2022 for an estimated value of 29.89K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+127.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bjarke Henric Bjorn's holdings
Insider Roles
SVP, COO
Roles that Bjarke Henric Bjorn holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bjarke Henric Bjorn
Bjarke Henric Bjorn's Trading History
IVERIC bio
Sep 02, 2015
―
Uninformative Buy
―
$51.94K
Inozyme Pharma
Dec 19, 2022
SVP, COO
Informative Buy
29.89K
$121.26K
List of latest transactions for each holding click on a transaction to see Bjarke Henric Bjorn's performance on stock
You May Also Like
Bjarke Henric Bjorn insider profile FAQ
What is the percentage of profitable transactions made by Bjarke Henric Bjorn?
The percentage of profitable transactions made by Bjarke Henric Bjorn is 100%.
What is the average return per transaction made by Bjarke Henric Bjorn?
The average return per transaction made by Bjarke Henric Bjorn is 127.90%.
What stocks does Bjarke Henric Bjorn hold?
Bjarke Henric Bjorn holds: ISEE, INZY stocks.
What was Bjarke Henric Bjorn’s latest transaction?
Bjarke Henric Bjorn latest transaction was an Informative Buy of $29.89K.
What was Bjarke Henric Bjorn's most profitable transaction?
Bjarke Henric Bjorn’s most profitable transaction was an Informative Buy of INZY stock on December 19, 2022. The return on the trade was 225.50%.
What is Bjarke Henric Bjorn's role in IVERIC bio?
Bjarke Henric Bjorn's role in IVERIC bio is SVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.